Health Condition 1: null- Children suffering from cystic fibrosis
Conditions
Interventions
Intervention1: Tablets of zinc: Enrolled subjects will get dispersible tablets containing zinc (30 mg) daily for a period of 12 months
Control Intervention1: Placebo: Enrolled children will get simila
Sponsors
Indian Council of Medical Reaserch
Eligibility
Inclusion criteria
Inclusion criteria: Children above the age of 5 years of either sex with cystic fibrosis (diagnosis based on two abnormal sweat chloride of > 60 mEq/l on two occasions in children with clinical features suggestive of cystic fibrosis).
Exclusion criteria
Exclusion criteria: 1.Children who are not willing to come for regular follow up. 2.Children who are on any zinc supplementation in last one month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average days of systemic antibiotics in the two groups over one year.Timepoint: At enrolment and end of one year | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Difference in FEV1 at 3, 6, 9 and 12 months in children above 5 years of age as measured by spirometry 2.Difference in colonization of airways with pseudomonas at 3, 6, 9 and 12 months Timepoint: At enrolment (Base line), 3, 6, 9 and 12 months | — |
Countries
India
Contacts
Public ContactDr S K kabra
All India Institute of Medical Sciences
Outcome results
None listed